{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:07:46Z","timestamp":1788865666524,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"crossref","award":["PON 03 PE_00060_07"],"award-info":[{"award-number":["PON 03 PE_00060_07"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Russian Foundation for Basic Research","award":["16-33-60003 mol_a_dk"],"award-info":[{"award-number":["16-33-60003 mol_a_dk"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejmech.2018.05.041","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T12:43:04Z","timestamp":1527511384000},"page":"946-960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO\/m-PGES-1 dual inhibitors able to suppress inflammation"],"prefix":"10.1016","volume":"155","author":[{"given":"Ferdinando","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suann","family":"Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim B.","family":"Nawrozkij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur S.","family":"Mkrtchyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Guida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Maisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahman","family":"Olga\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabatino","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4737-1733","authenticated-orcid":false,"given":"Erden","family":"Banoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Werz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9439-7074","authenticated-orcid":false,"given":"Antonio","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8728-061X","authenticated-orcid":false,"given":"Rosanna","family":"Filosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.05.041_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.pharmthera.2006.05.009","article-title":"Therapeutic options for 5-lipoxygenase inhibitors","volume":"112","author":"Werz","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2018.05.041_bib2","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.05.041_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tibs.2007.06.002","article-title":"5-Lipoxygenase: regulation of expression and enzyme activity","volume":"32","author":"Radmark","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2018.05.041_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2005.12.070","article-title":"Treatment of asthma with antileukotrienes: first line or last resort therapy?","volume":"533","author":"Dahl\u00e9n","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.05.041_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2796.2010.02246.x","article-title":"Microsomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancer","volume":"268","author":"Radmark","year":"2010","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.ejmech.2018.05.041_bib6","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/j.1476-5381.2011.01707.x","article-title":"Molecular pharmacological profile of a novel thiazolinone-based direct and selective 5-lipoxygenase inhibitor","volume":"165","author":"Hofmann","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.05.041_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","article-title":"The role of oxidative stress in the pathogenesis of age-related macular degeneration","volume":"45","author":"Beatty","year":"2000","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejmech.2018.05.041_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1096\/fasebj.12.6.439","article-title":"Aging-associated upregulation of neuronal 5-lipoxygenase expression: putative role in neuronal vulnerability","volume":"12","author":"Uz","year":"1998","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejmech.2018.05.041_bib9","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.neurobiolaging.2006.06.007","article-title":"The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old","volume":"28","author":"Chinnici","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2018.05.041_bib10","article-title":"Oxidation and age-related macular degeneration: insights from molecular biology","volume":"12","author":"Khandhadia","year":"2010","journal-title":"Expet Rev. Mol. Med."},{"key":"10.1016\/j.ejmech.2018.05.041_bib11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3109\/02713689508998521","article-title":"Lipid mediators in the rat retina: light exposure and trauma elicit leukotriene B4 release in\u00a0vitro","volume":"14","author":"Reinboth","year":"1995","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejmech.2018.05.041_bib12","unstructured":"U.S. patent application no. 13\/098,200, filed on 4\/29\/2011."},{"key":"10.1016\/j.ejmech.2018.05.041_bib13","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1517\/13543776.2013.791678","article-title":"5-Lipoxygenase inhibitors: a review of recent patents","volume":"7","author":"Hofmann","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2018.05.041_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/phrs.2000.0784","article-title":"Laufer S. Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept","volume":"43","author":"Celotti","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2018.05.041_bib15","series-title":"Compositions Including Leukotriene Antagonists and Nsaids and Methods of Using the Same","author":"Logigal Therapeutics INC","year":"2009"},{"key":"10.1016\/j.ejmech.2018.05.041_bib16","doi-asserted-by":"crossref","first-page":"14507","DOI":"10.1073\/pnas.0606586103","article-title":"Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis","volume":"103","author":"Wang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2018.05.041_bib17","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.05.041_bib18","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa050330","article-title":"Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery","volume":"352","author":"Nussmeier","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.05.041_bib19","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.286.8.954","article-title":"Risk of cardiovascular events associated with selective COX-2 inhibitors","volume":"286","author":"Mukherjee","year":"2001","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.ejmech.2018.05.041_bib20","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.1021\/jm801085s","article-title":"Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase","volume":"51","author":"Koeberle","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib21","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1021\/jp100668y","article-title":"Understanding microscopic binding of human microsomal prostaglandin E synthase-1 (mPGES-1) trimer with substrate and cofactor GSH: insights from PGH2 computational alanine scanning and site-directed mutagenesis","volume":"114","author":"Hamza","year":"2010","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2018.05.041_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10822-008-9233-4","article-title":"Homo-timeric structural model of human microsomal prostaglandin E synthase-1 and characterization of its substrate\/inhibitor binding interactions","volume":"23","author":"Xing","year":"2009","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2018.05.041_bib23","doi-asserted-by":"crossref","first-page":"9044","DOI":"10.1073\/pnas.1332766100","article-title":"Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase","volume":"100","author":"Trebino","year":"2003","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2018.05.041_bib24","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1074\/jbc.M213290200","article-title":"Potential role of microsomalprostaglandin E synthase-1 in tumorigenesis","volume":"278","author":"Kamei","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib25","doi-asserted-by":"crossref","first-page":"33684","DOI":"10.1074\/jbc.M400199200","article-title":"Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1","volume":"279","author":"Kamei","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib26","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.2174\/092986709789578178","article-title":"Inhibitors of the microsomal prostaglandin E(2) Synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs) - a critical review","volume":"32","author":"Koeberle","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bmc.2008.11.024","article-title":"Molecular modelling studies, synthesis and biological activity of a series of novel bisnaphthalimides and their development as new DNA topoisomerase II inhibitors","volume":"17","author":"Filosa","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib28","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1016\/j.bmc.2011.08.062","article-title":"Design, synthesis, biophysical and biological studies of trisubstituted naphthalimides as G-quadruplex ligands","volume":"19","author":"Petronzi","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/138955711795843383","article-title":"Synthesis and cytotoxic activity of new b-carboline derivatives","volume":"11","author":"Peduto","year":"2011","journal-title":"Mini rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ejmech.2010.11.028","article-title":"Structure-based design, synthesis and preliminary anti-inflammatory activity of bolinaquinone analogues","volume":"46","author":"Petronzi","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejmech.2013.06.039","article-title":"Discovery and biological evaluation of novel 1,4-benzoquinone and related resorcinol derivatives that inhibit 5-lipoxygenase","volume":"67","author":"Filosa","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib32","article-title":"Cyclohexa-2,5-diene-1,4-dione-based antiproliferative agents: design, synthesis, and cytotoxic evaluation","volume":"32","author":"Petronzi","year":"2013","journal-title":"J.\u00a0Exp. Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2018.05.041_bib33","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bcp.2013.04.015","article-title":"Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin","volume":"86","author":"Schaible","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.05.041_bib34","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1111\/bph.12592","article-title":"Elucidation of the molecular mechanism and the efficacy in\u00a0vivo of a novel 1,4-benzoquinone that inhibits 5-lipoxygenase","volume":"171","author":"Schaible","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.05.041_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejmech.2015.02.042","article-title":"Novel series of benzoquinones with high potency against 5-lipoxygenase in human polymorphonuclear leukocytes","volume":"24","author":"Filosa","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bcp.2016.04.019","article-title":"The 5-lipoxygenase inhibitor RF-22c potently suppresses leukotriene biosynthesis in cellulo and blocks bronchoconstriction and inflammation in\u00a0vivo","volume":"16","author":"Schaible","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.05.041_bib37","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3390\/molecules22111831","article-title":"Binding of harmine derivatives to DNA: a spectroscopic investigation","volume":"22","author":"Pagano","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.05.041_bib38","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ejmech.2016.10.046","article-title":"Optimization of benzoquinone and hydroquinone derivatives as potent inhibitors of human 5-lipoxygenase","volume":"127","author":"Peduto","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmech.2017.10.020","article-title":"Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma","volume":"153","author":"Bruno","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib40","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cmdc.200500071","article-title":"Synthesis and preliminary biological evaluation of 2\u2032-substituted 2-(3\u2032-carboxybicyclo[1.1.1]pentyl)glycine derivatives as group I selective metabotropic glutamate receptor ligands","volume":"1","author":"Pellicciari","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.05.041_bib41","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1016\/j.bmc.2006.01.027","article-title":"R.Pellicciari Synthesis and biological evaluation of (2S)- and (2R)-2-(3'-phosphonobicyclo[1.1.1]pentyl)glycines as novel group III selective metabotropic glutamate receptor ligands","volume":"14","author":"Filosa","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib42","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1016\/j.bmc.2014.09.013","article-title":"Structure-activity relationship study of arbidol derivatives as inhibitors of chikungunya virus replication","volume":"22","author":"Di Mola","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2013.05.005","article-title":"Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in\u00a0vitro antiviral activity of a novel indole series","volume":"99","author":"Brancato","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2018.05.041_bib44","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1099\/jmm.0.076612-0","article-title":"In\u00a0vitro antiviral and immunomodulatory activity of arbidol and structurally related derivatives in herpes simplex virus type 1-infected human keratinocytes (HaCat)","volume":"63","author":"Perfetto","year":"2014","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.ejmech.2018.05.041_bib45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bmc.2016.10.037","article-title":"Discovery of novel multi-target indole-based derivatives as potent and selective inhibitors of chikungunya virus replication","volume":"25","author":"Scuotto","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejmech.2014.05.033","article-title":"Further studies on ethyl 5-hydroxyindole-3-carboxylate scaffold: design, synthesis and evaluation of 2-phenylthiomethyl-indole derivatives as efficient inhibitors of human 5-lipoxygenase","volume":"81","author":"Peduto","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib47","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejmech.2015.11.048","article-title":"Exploring the role of chloro and methyl substitutions in 2-phenylthiomethyl-benzoindole derivatives for 5-LOX enzyme inhibition","volume":"27","author":"Peduto","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib48","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/jm900212y","article-title":"Structural optimization and biological evaluation of 2-substituted 5-hydroxyindole-3-carboxylates as potent inhibitors of human 5-lipoxygenase","volume":"52","author":"Karg","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib49","doi-asserted-by":"crossref","first-page":"7924","DOI":"10.1016\/j.bmc.2009.10.025","article-title":"Discovery of benzo[g]indol-3-carboxylates as potent inhibitors of microsomal prostaglandin E(2) synthase-1","volume":"23","author":"Koeberle","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1197203","article-title":"The structure of human 5-lipoxygenase","volume":"331","author":"Gilbert","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.05.041_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2016.02.027","article-title":"4,5-Diarylisoxazol-3-carboxylic acids: a new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein (FLAP)","volume":"113","author":"Banoglu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejmech.2012.05.014","article-title":"Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors","volume":"54","author":"Chini","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/minf.201100101","article-title":"From molecular docking to 3d-quantitative structure-activity relationships (3d-QSAR): insights into the binding mode of 5-lipoxygenase inhibitors","volume":"31","author":"Eren","year":"2012","journal-title":"Mol. Inf."},{"key":"10.1016\/j.ejmech.2018.05.041_bib54","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1021\/jm050870x","article-title":"Structural insights into human 5-lipoxygenase inhibition: combined ligand-based and target-based approach","volume":"49","author":"Charlier","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib55","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1021\/acs.jmedchem.5b01750","article-title":"Design and development of microsomal prostaglandin E2 Synthase-1 inhibitors: challenges and future directions","volume":"59","author":"Koeberle","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib56","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1021\/acs.jmedchem.5b00330","article-title":"Crystal structures of mPGES-1 inhibitor complexes form a basis for the rational design of potent analgesic and anti-inflammatory therapeutics","volume":"58","author":"Luz","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.041_bib57","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/bioinformatics\/btk023","article-title":"OPM: orientations of proteins in membranes database","volume":"22","author":"Lomize","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2018.05.041_bib58","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ymeth.2006.08.006","article-title":"Setting up and running molecular dynamics simulations of membrane proteins","volume":"41","author":"Kandt","year":"2007","journal-title":"Methods"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418304549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418304549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T22:53:53Z","timestamp":1720306433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418304549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":58,"alternative-id":["S0223523418304549"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.05.041","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO\/m-PGES-1 dual inhibitors able to suppress inflammation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.05.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}